Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
583,357,497
-
Share change
-
-3,637,705
-
Total reported value
-
$5,716,381,171
-
Put/Call ratio
-
197%
-
Price per share
-
$9.80
-
Number of holders
-
392
-
Value change
-
-$12,628,622
-
Number of buys
-
160
-
Number of sells
-
177
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q4 2019
As of 31 Dec 2019,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
392 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
583,357,497 shares.
The largest 10 holders included
Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, Berkshire Hathaway Inc, BlackRock Inc., Capital World Investors, ABRAMS CAPITAL MANAGEMENT, L.P., FRANKLIN RESOURCES INC, Migdal Insurance & Financial Holdings Ltd., STATE STREET CORP, and MILLER VALUE PARTNERS, LLC.
This page lists
393
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.